Skip to main content
. 2018 Feb 20;7(2):36. doi: 10.3390/jcm7020036

Figure 1.

Figure 1

Blood mononuclear cell Complex IV activity, expressed as a ratio to citrate synthase, in control individuals, MS patients and MS patients receiving β-interferon (IFN). * Statistically different from both control and MS patients receiving β-interferon.